Title | Description |
|---|---|
| Trial ID | KF10004/02 |
| Compound | 5% Lidocaine medicated plaster |
| Trials sponsor | Grünenthal GmbH |
| Trial phase | 3 |
| Brief title | A clinical trial to find out how much tapentadol is in the blood of children who take tapentadol every 4 hours to treat short-term pain |
| Indication | Postherpetic neuralgia |
| UTN | |
| CTG ID | NCT03765697 |
| CTIS ID (former EudraCT) | |
| Trial status | Completed |
| FPI | July 16, 2003 |
| LPO | July 12, 2005 |
| Countries | France, Germany, Poland, Spain, United Kingdom |
| Gender | All |
| Age | >= 18 years of age |
| Results | No |
| Pubmed | |
| Documents |
External Link
You are now leaving the Grünenthal website. You will be re-directed to an external website. Grünenthal accepts no responsibility for the content of other websites.